Evaluation by Multivariate Analysis of the Differentiation Inhibitory Factor nm23 as a Prognostic Factor in Acute Myelogenous Leukemia and Application to Other Hematologic MalignanciesAkihiro Yokoyama, Yoshio Honma, Junko Okabe‐Kado et al.|Blood|1998Cited by 46
Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hopYoshio Honma, Junko Okabe‐Kado, Akihiro Yokoyama et al.|Leukemia Research|1998Cited by 34
Anticancer Derivative of Butyric Acid (Pivalyloxymethyl Butyrate) Specifically Potentiates the Cytotoxicity of Doxorubicin and Daunorubicin through the Suppression of Microsomal Glycosidic ActivityNozomi Niitsu, Yoshio Honma, Takashi Kasukabe et al.|Molecular Pharmacology|2000Cited by 33
MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemiaAkihiro Yokoyama, Takashi Kasukabe, Takuya Yamashita et al.|Leukemia Research|2003Cited by 28
Angelmicin b, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cellsAkihiro Yokoyama, Yoshio Honma, Junko Okabe‐Kado et al.|Leukemia Research|1996Cited by 15